share_log

天茂集团(000627.SZ):尚未回购公司股份

Hubei Biocause Pharmaceutical (000627.SZ): has not yet repurchased company shares.

Gelonghui Finance ·  Mar 3 08:38

Glory Financial reported on March 3rd that Hubei Biocause Pharmaceutical (000627.SZ) announced that as of the close on March 3, 2025, the company's stock price was 3.88 yuan per share, exceeding the upper limit of the company's stock repurchase price. The company has cumulatively repurchased 0 shares through a designated securities account for stock repurchase via centralized bidding, which accounts for 0.00% of the company's current total share capital.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 276

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.